Autonomic neuropathy is a debilitating complication of diabetes mellitus. Once autonomic dysfunction is established the disorder is progressive and affects multiple organ systems. Current therapies for this syndrome are frequently unsatisfactory, and fail to arrest or reverse the underlying disease process. We suspect that therapeutic intervention in diabetic autonomic neuropathy, in order to be successful, must be instituted at an early stage in this disorder. Currently there is no way of predicting autonomic dysfunction in diabetic patients prior to the onset of symptoms. Although autonomic reflex tests have made it possible to diagnose autonomic involvement early in the natural history of diabetes, there is no evidence that asymptomatic patients who perform poorly on autonomic function tests are likely to develop clinical symptoms of autonomic neuropathy. For this reason we are interested in developing other methods for diagnosing early autonomic involvement in diabetes. Our hypothesis is that incipient diabetic autonomic neuropathy can be predicted in patients who show evidence of decreased norepinephrine production.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK032239-06
Application #
3230668
Study Section
Neurology A Study Section (NEUA)
Project Start
1983-12-01
Project End
1992-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Temple University
Department
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Hoeldtke, Robert D; Bryner, Kimberly D; Hoeldtke, Martin E et al. (2006) Sympathetic sudomotor disturbance in early type 1 diabetes mellitus is linked to lipid peroxidation. Metabolism 55:1524-31
Hoeldtke, Robert D; Bryner, Kimberly D; McNeill, Daniel R et al. (2003) Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J Clin Endocrinol Metab 88:1624-8
Hoeldtke, Robert D; Bryner, Kimberly D; McNeill, Daniel R et al. (2003) Peroxynitrite versus nitric oxide in early diabetes. Am J Hypertens 16:761-6
Hoeldtke, R D; Bryner, K D; Horvath, G G et al. (2001) Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes 50:436-43
Hoeldtke, R D; Bryner, K D; Hobbs, G R et al. (2000) Antibodies to glutamic acid decarboxylase and peripheral nerve function in type 1 diabetes. J Clin Endocrinol Metab 85:3297-308
Hoeldtke, R D; Bryner, K D; Komanduri, P et al. (2000) Decreased prorenin processing develops before autonomic dysfunction in type 1 diabetes. J Clin Endocrinol Metab 85:585-9
Hoeldtke, R D; Horvath, G G; Bryner, K D et al. (1998) Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab 83:339-43
Hoeldtke, R D; Bryner, K D; Horvath, G G et al. (1997) Antibodies to GAD and glycemic control in recent-onset IDDM. Diabetes Care 20:1900-3
Hoeldtke, R D; Boden, G (1994) Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med 120:512-7
Boden, G; Tappy, L; Jadali, F et al. (1990) Role of glucagon in disposal of an amino acid load. Am J Physiol 259:E225-32